OUR STORY
At EBRP, we have one bold audacious goal: heal and cure EB by 2030. In the process, we’re pioneering a model that can benefit the more than 400 million people affected by a rare disease. We are proud of the progress being made towards achieving that goal and more inspired than ever to continue advancing life-saving treatments and cures for EB families across the globe.
|
Epidermolysis Bullosa (EB) is a rare and life-threatening genetic skin disorder that affects children from birth.
|
We're building a faster path to heal EB. Our innovative model puts speed in the system to find cures quickly.
|
Committed to financial responsibility. With the highest charity ratings, we ensure your dollars make an impact.
|